Management of immune-related adverse events

被引：0
|
作者：
Princk, Marika Henriette [1 ,2 ]
Pervan, Mascha [3 ]
Riedl, Joerg [1 ]
机构：
[1] Univ Klinikum Schleswig Holstein, Univ Canc Ctr Schleswig Holstein, Campus Lubeck, Lubeck, Germany
[2] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde & Geburtshilfe, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany
[3] Univ Klinikum Munster UKM, Klin Gynakol & Geburtshilfe, Munster, Germany
来源：
UROLOGIE | 2025年
关键词：
Immune checkpoint inhibitors; Pembrolizumab; Atezolizumab; Corticosteroids; Autoimmunity;
D O I：
10.1007/s00120-024-02517-x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
With the implementation of immunotherapy, a completely new, broad spectrum of side effects has emerged in oncology-the immune-related adverse events (irAEs). Their management differs greatly from that of classic cytotoxic side effects and is based primarily on corticosteroids, immunomodulatory agents, and treatment interruptions. Whereas some events are low grade and reversible, others can be severe and lead to permanent disorders or even death. Therefore, early recognition and treatment in the context of interdisciplinary side effects management is critical for patients' safety, prognosis, and quality of life.
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Immune-related adverse events: A bibliometric analysis
    Jiang, Shi-Tao
    Liu, Yao-Ge
    Zhang, Lei
    Sang, Xin-Ting
    Xu, Yi-Yao
    Lu, Xin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Immune-related adverse events of checkpoint inhibitors
    Ramos-Casals, Manuel
    Brahmer, Julie R.
    Callahan, Margaret K.
    Flores-Chavez, Alejandro
    Keegan, Niamh
    Khamashta, Munther A.
    Lambotte, Olivier
    Marlette, Xavier
    Prat, Aleix
    Suarez-Almazor, Maria E.
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [33] Immune-related adverse events of checkpoint inhibitors
    Manuel Ramos-Casals
    Julie R. Brahmer
    Margaret K. Callahan
    Alejandra Flores-Chávez
    Niamh Keegan
    Munther A. Khamashta
    Olivier Lambotte
    Xavier Mariette
    Aleix Prat
    Maria E. Suárez-Almazor
    Nature Reviews Disease Primers, 6
  • [34] Immune-Related Adverse Events of the Gastrointestinal System
    Nicolaides, Steven
    Boussioutas, Alex
    CANCERS, 2023, 15 (03)
  • [35] Atezolizumab/bevacizumabBleeding and immune-related adverse events
    Reactions Weekly, 2024, 1998 (1) : 84 - 84
  • [36] Immune-related adverse events of checkpoint inhibitors
    不详
    Nature Reviews Disease Primers, 6 (1) : 39
  • [37] Immune-related Adverse Events in Cancer Patients
    Pallin, Daniel J.
    Baugh, Christopher W.
    Postow, Michael A.
    Caterino, Jeffrey M.
    Erickson, Timothy B.
    Lyman, Gary H.
    ACADEMIC EMERGENCY MEDICINE, 2018, 25 (07) : 819 - 827
  • [38] Advanced materials for management of immune-related adverse events induced by immune checkpoint inhibitors
    Zheng, Lingnan
    Yang, Xi
    Wei, Yuanfeng
    You, Jia
    Li, Huawei
    Liao, Jinfeng
    Yi, Cheng
    MATERIALS & DESIGN, 2022, 219
  • [39] Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
    Jeung, Hei-Cheul
    Oh, Se Eung
    Kim, Jee Hung
    JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (04): : 221 - 234
  • [40] Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management
    Ruggiero, Rosanna
    Di Napoli, Raffaella
    Balzano, Nunzia
    Ruggiero, Donatella
    Riccardi, Consiglia
    Anatriello, Antonietta
    Cantone, Andrea
    Sportiello, Liberata
    Rossi, Francesco
    Capuano, Annalisa
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (05) : 423 - 434
12345